BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21081718)

  • 1. FDA warning targets OTC chelation products.
    Voelker R
    JAMA; 2010 Nov; 304(19):2112. PubMed ID: 21081718
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA expands warning on diet products.
    Voelker R
    JAMA; 2009 Apr; 301(16):1646. PubMed ID: 19383948
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA faces barrage of criticism over plans to assess safety of supplements.
    Epstein K
    BMJ; 2012 Jan; 344():e583. PubMed ID: 22277134
    [No Abstract]   [Full Text] [Related]  

  • 4. Risky pills: supplements to avoid.
    Consum Rep; 2008 Jan; 73(1):46-7. PubMed ID: 18488285
    [No Abstract]   [Full Text] [Related]  

  • 5. "Tag--we're it".
    Czap A
    Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA regulation of OTC oral health care drug products.
    Rippere JL
    J Public Health Dent; 1992; 52(6):329-32. PubMed ID: 1432917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male enhancement products: kudos to the FDA.
    Gomella LG
    Can J Urol; 2010 Oct; 17(5):5343. PubMed ID: 20974023
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal regulation of unapproved chelation products.
    Lee CE
    J Med Toxicol; 2013 Dec; 9(4):313-7. PubMed ID: 24197664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA launches campaign on OTC pain relief products.
    FDA Consum; 2004; 38(2):8. PubMed ID: 15101357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
    Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA Warns Against Unregulated Products.
    Aschenbrenner DS
    Am J Nurs; 2018 Mar; 118(3):22-23. PubMed ID: 29470211
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA yanks leg cramp products off the OTC market.
    Chase SL
    RN; 1995 May; 58(5):71. PubMed ID: 7747043
    [No Abstract]   [Full Text] [Related]  

  • 14. OTC supplements: healthy or not?
    Laskowski-Jones L
    Nursing; 2014 Nov; 44(11):6. PubMed ID: 25271731
    [No Abstract]   [Full Text] [Related]  

  • 15. A sad day for science at the FDA.
    Grant EC
    N Engl J Med; 2005 Dec; 353(24):2619-21; author reply 2619-21. PubMed ID: 16363031
    [No Abstract]   [Full Text] [Related]  

  • 16. New warning issued on OTC analgesics.
    Chase SL
    RN; 1999 Mar; 62(3):93. PubMed ID: 10205570
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of "natural products" in clinical medicine.
    Farver D
    S D J Med; 1996 Apr; 49(4):129-30. PubMed ID: 8936438
    [No Abstract]   [Full Text] [Related]  

  • 18. OTC survival guide. FAQs on OTCs. Here are answers to your questions about over-the-counter remedies.
    Quartetti HR
    Diabetes Forecast; 2004 Feb; 57(2):68-71. PubMed ID: 14976939
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral chelation products.
    Nightingale SL
    Am Fam Physician; 1986 Mar; 33(3):325. PubMed ID: 3953347
    [No Abstract]   [Full Text] [Related]  

  • 20. Are non-prescription medications needed for weight control?
    Bray GA
    Obesity (Silver Spring); 2008 Mar; 16(3):509-14. PubMed ID: 18239604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.